Polymarket market
Hantavirus vaccine in 2026? is a Polymarket prediction market. The market currently gives ‘Yes’ 3% and ‘No’ 97%. Ends Dec 31, 2026 · $143k traded.
| Yes | 3% |
|---|---|
| No | 97% |
Ends Dec 31, 2026 · $143k traded
Odds as of 05:23 UTC, Nov 13, 2026.
How to read these odds: a share in an outcome costs its chance in cents and pays one dollar if that outcome happens. ‘Yes’ at 3% means a share costs about 3 cents and returns about 31.3 times the stake on a win. The prices are Polymarket’s and move with every trade on its order book, so they are a live reading of what traders expect.
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
On Polymarket, every position on Hantavirus vaccine in 2026? sits on a public profile: anyone can see which account holds what, how much, and since when. On OffMarket you trade the same market, through the same order book, at the same odds, with positions that are not publicly linked to your account.
Odds are Polymarket’s and move with its order book. On OffMarket you trade this market at the same odds, with positions that are not publicly linked to your account.
Open Hantavirus vaccine in 2026? on OffMarket
OffMarket is not affiliated with Polymarket. Read the OffMarket privacy policy and terms of service. Support: Telegram.